The Cooper Companies have announced two major management changes. Holly Sheffield has been named executive vice-president and chief strategy officer, effective June 4. She will be responsible for corporate strategy, business development and global human resources, reporting directly to Cooper's president and chief executive, Albert White. Sheffield joins Cooper from UBS Securities, where she served as global head of medical technology within the firms' Healthcare Banking group. Prior to UBS, she spent 13 years at Credit Suisse, where she was a managing director in Healthcare Banking in San Francisco and New York. In addition, Robert Auerbach, executive vice-president, chief strategy officer and chief medical officer of CooperSurgical, has been promoted to president of CooperSurgical. He succeeds Paul Remmell, who has transitioned out of the company after a 27-year career. In his new role, Auerbach is responsible for CooperSurgical's worldwide business. He is also reporting directly to White. Prior to joining CooperSurgical in 2005, Auerbach was a member of Yale's clinical faculty in the School of Medicine.